TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.56B
AUM Growth
-$71.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
186
New
Increased
Reduced
Closed

Top Buys

1 +$20M
2 +$14.2M
3 +$14.1M
4
PODD icon
Insulet
PODD
+$13.3M
5
BAX icon
Baxter International
BAX
+$11.2M

Top Sells

1 +$31.7M
2 +$22.5M
3 +$22.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$13.8M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$13.7M

Sector Composition

1 Healthcare 96.11%
2 Real Estate 2.09%
3 Industrials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALT icon
151
Altimmune
ALT
$521M
$265K 0.01%
75,000
FUSN
152
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$203K 0.01%
43,394
CDXS icon
153
Codexis
CDXS
$92.1M
$194K 0.01%
69,125
HARP
154
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$185K 0.01%
25,991
DTIL icon
155
Precision BioSciences
DTIL
$104M
$118K ﹤0.01%
7,484
SPPI
156
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$110K ﹤0.01%
114,670
ACET icon
157
Adicet Bio
ACET
$70M
$98K ﹤0.01%
2,521
PRAX icon
158
Praxis Precision Medicines
PRAX
$9.17B
$86.3K ﹤0.01%
5,000
ORKA
159
Oruka Therapeutics
ORKA
$1.63B
$65.9K ﹤0.01%
2,705
NKTX icon
160
Nkarta
NKTX
$192M
$63.5K ﹤0.01%
28,988
MNK
161
DELISTED
Mallinckrodt plc
MNK
$41.4K ﹤0.01%
35,048
CRBP icon
162
Corbus Pharmaceuticals
CRBP
$147M
$40.3K ﹤0.01%
5,143
VYNE icon
163
VYNE Therapeutics
VYNE
$20.1M
$30.5K ﹤0.01%
7,520
NXGL icon
164
NexGel
NXGL
$9.2M
$10.7K ﹤0.01%
4,243
BLCM
165
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.22K ﹤0.01%
6,000
ADUS icon
166
Addus HomeCare
ADUS
$1.95B
-42,380
ALGN icon
167
Align Technology
ALGN
$13.6B
-6,925
AMED
168
DELISTED
Amedisys
AMED
-68,949
ARWR icon
169
Arrowhead Research
ARWR
$9.01B
-100,422
BHVN icon
170
Biohaven
BHVN
$1.57B
-35,087
BPMC
171
DELISTED
Blueprint Medicines
BPMC
-67,710
KURA icon
172
Kura Oncology
KURA
$755M
-283,281
LH icon
173
Labcorp
LH
$23.5B
-46,609
LNTH icon
174
Lantheus
LNTH
$5.06B
-79,495
MRSN
175
DELISTED
Mersana Therapeutics
MRSN
-6,495